Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

f.e. venture sdn. bhd. - lincomycin hydrochloride -

Philippines - English - FDA (Food And Drug Administration)

scuderia marketing and distribution corporation; distributor: scuderia marketing and distribution corporation - lincomycin (vet.) - feed premix powder - 44 g/ 100 g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

syntofarma, s.a. - cefalexina (monohidrato) - cefalexina (monohidrato)....500mg *

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

syntofarma, s.a. - cefadroxilo (monohidrato) - cefadroxilo (monohidrato)....250 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

syntofarma, s.a. - cefalexina (monohidrato) - cefalexina (monohidrato)....250 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

syntofarma s.a. de colombia - cefalexina (monohidrato) - cefalexina (monohidrato)....

Malta - English - Medicines Authority

especialidades farmaceuticas centrium sa laboratories centrum s.a., c/ sagitario, 14 03006 alicante, spain - omeprazole - hard capsule - omeprazole 20 mg - drugs for acid related disorders

Israel - English - Ministry of Health

cts ltd - baclofen - solution for infusion - baclofen 2 mg/ml - baclofen - baclofen sintetica is indicated in patients with severe chronic spasticity resulting from trauma, multiple sclerosis or other spinal cord disorders, who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side effects at effective oral doses.baclofen sintetica is effective in adult patients with severe chronic spasticity of cerebral origin, resulting e.g. from cerebral palsy, brain trauma or cerebrovascular accident; however, clinical experience is limited.paediatric population: baclofen sintetica indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Israel - English - Ministry of Health

cts ltd - baclofen - solution for infusion - baclofen 0.5 mg / 1 ml - baclofen - baclofen sintetica is indicated in patients with severe chronic spasticity resulting from trauma, multiple sclerosis or other spinal cord disorders, who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side effects at effective oral doses.baclofen sintetica is effective in adult patients with severe chronic spasticity of cerebral origin, resulting e.g. from cerebral palsy, brain trauma or cerebrovascular accident; however, clinical experience is limited.paediatric population: baclofen sintetica indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

United States - English - NLM (National Library of Medicine)

nartex laboratorios homeopaticos sa de cv - each dose contains equal parts of:, arnica montana tinc hpus, hamamelis virginiana tinc hpus, the letters "hpus" indicate that the components in this product are officially monographed in the homeopathic pharmacopoeia of the untied states. - arnica montana tinc hpus......................anti-inflammatory/pain relief hamamelis virginiana tinc hpus.............anti-inflammatory/pain relief temporary relief for the symptoms of sore muscles, bruises and sprains.